Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case–control matched multicentre study (BACTCOVID)
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 27 (11) , 1685-1692
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infectionJournal of Antimicrobial Chemotherapy, 2017
- Increased incidence of co-infection in critically ill patients with influenzaIntensive Care Medicine, 2016
- D-dimer and histamine in early stage bacteremia: A prospective controlled cohort studyEuropean Journal of Internal Medicine, 2015
- Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysisClinical Microbiology and Infection, 2015
- Polymicrobial bloodstream infections: Epidemiology and impact on mortalityJournal of Global Antimicrobial Resistance, 2013
- Increase in Bloodstream Infection Due to Vancomycin-Susceptible Enterococcus faecium in Cancer Patients: Risk Factors, Molecular Epidemiology and OutcomesPLOS ONE, 2013
- The Occurrence and Impact of Bacterial Organisms Complicating Critical Care Illness Associated With 2009 Influenza A(H1N1) InfectionChest, 2013
- Nurse staffing, burnout, and health care–associated infectionAmerican Journal of Infection Control, 2012
- Acquired bloodstream infection in the intensive care unit: incidence and attributable mortalityCritical Care, 2011
- Nurse-Staffing Levels and the Quality of Care in HospitalsNew England Journal of Medicine, 2002